Category Press Releases

Satellos Names Dr. Wildon Farwell as Chief Medical Officer to Lead Clinical Strategy

Satellos Bioscience Names Renowned Neuromuscular Expert Dr. Wildon Farwell as Chief Medical Officer to Advance Duchenne Therapy Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF), a biotechnology company pioneering small molecule therapies to treat muscle diseases, has appointed Dr. Wildon Farwell,…

Read MoreSatellos Names Dr. Wildon Farwell as Chief Medical Officer to Lead Clinical Strategy

C2N Diagnostics Expands Alzheimer’s Blood Test Portfolio for Researchers

C2N Diagnostics Unveils Two Groundbreaking Blood Tests to Advance Alzheimer’s Research and Precision Diagnostics C2N Diagnostics, LLC, a trailblazer in brain health diagnostics, has announced the launch of two innovative plasma-based assays designed for Research Use Only, expanding its suite…

Read MoreC2N Diagnostics Expands Alzheimer’s Blood Test Portfolio for Researchers

HistoSonics Secures Coverage for Liver Tumor Therapy in 7M Highmark Members

HistoSonics Expands Access to Groundbreaking Non-Invasive Liver Tumor Treatment as Highmark Covers Histotripsy for 7 Million Members In a pivotal development for patients battling liver tumors, HistoSonics, the medical technology company behind the innovative Edison® Histotripsy System, announced that Highmark…

Read MoreHistoSonics Secures Coverage for Liver Tumor Therapy in 7M Highmark Members

Walgreens Boots Alliance Shareholders Greenlight Sycamore Partners Deal

Walgreens Boots Alliance Shareholders Overwhelmingly Approve Acquisition by Sycamore Partners Walgreens Boots Alliance, announced a significant milestone on the path to its planned acquisition by Sycamore Partners Management, L.P. Shareholders of the global pharmacy-led health and retail company voted overwhelmingly…

Read MoreWalgreens Boots Alliance Shareholders Greenlight Sycamore Partners Deal

UN Agencies Unveil Report on Leveraging AI in Traditional Medicine

AI Meets Ancient Wisdom: UN Agencies Launch Report on Artificial Intelligence in Traditional Medicine Artificial intelligence (AI) is opening new frontiers for traditional medicine, combining centuries-old healing practices with cutting-edge technologies to enhance safety, personalization, effectiveness, and accessibility of care.…

Read MoreUN Agencies Unveil Report on Leveraging AI in Traditional Medicine

AbbVie and IGI Announce Exclusive Worldwide Licensing Deal for First-in-Class Trispecific Antibody ISB 2001

AbbVie and IGI Therapeutics Sign Exclusive Global Licensing Agreement for Trispecific Antibody ISB 2001 AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of Ichnos Glenmark Innovation, Inc. (IGI), today announced an exclusive global licensing agreement for ISB 2001, IGI’s…

Read MoreAbbVie and IGI Announce Exclusive Worldwide Licensing Deal for First-in-Class Trispecific Antibody ISB 2001

Sickle Cell Disease Treatment Market Outlook 2025–2035: R&D, Patents, Pipeline & Regulations

Global Sickle Cell Disease Treatment Market Poised for Robust Growth Through 2035 The global sickle cell disease (SCD) treatment market is set to witness substantial growth from 2025 to 2035, driven by increasing disease prevalence, advancements in therapeutic development, and…

Read MoreSickle Cell Disease Treatment Market Outlook 2025–2035: R&D, Patents, Pipeline & Regulations